Volume 5  Issue 1

AstraZeneca-Oxford and Moderna Future Vaccines and Remdesivir, Dexamethasone as a Palliative Remedy and Anger at the Biological Institute in Israel. Meanwhile - High Hopes

Shimon Shatzmiller

Two months after the first cases of atypical pneumonia were reported in Wuhan, China.
Four months later, there are at least 130 vaccine candidates being developed by biotech and pharmaceutical companies, as well as academic groups around the world. [..] READ MORE

View Full Text | Download PDF

Histopathological Study in Alloxan-Induced Diabetic Mice Treated With Tapinanthus globiferus Flowers Extract

Mofeed Al- Nowihi1*, Maher Al-Absi2, Abdu Faisal2, Fatima Al-Futaini1 & Gawed Al- Asbhai

Objectives
The aim of this study is to investigate the capacity of flower extracts of Tapinanthus globiferus to reverse pancreatic injuries in alloxan-induced hyperglycemic mice.
Introduction
Diabetes mellitus (DM) is a chronic metabolic disorder, which affects over 150 million people in the world today, and this will be doubled by 2025. DM is considered the sixth leading cause of death globally. [..] READ MORE

View Full Text | Download PDF

Cessation of the Interoception, the Death Due to Brain in Neurodegenerative Diseases Alzheimer's and COVID-19

Shimon Shatzmiller

Interoception [1] refers to the process by which nervous systems senses, interprets, incorporates signals originating within the body, and providing moment-to-moment control of the body's internal organs across conscious and unconscious systems. Conceptual facial signaling is considered a component process of Reflexes, impulses, emotions, drives, adaptive responses, [..] READ MORE

View Full Text | Download PDF

Coronavirus Disease 2019 COVID-19, or Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Amr Saeb, T. M.1, Shatha Makki, M.2 & Hamsa Tayeb, T.3,4*

The current novel coronavirus (COVID-19) outbreak is regarded as a crucial public health emergency of international concern (PHEIC). It is involving a novel type of coronavirus initially identified in Wuhan, China. At the time of writing, there have been 167511 confirmed cases around the world with 6606 deaths. [..] READ MORE

View Full Text | Download PDF

Evaluation of Fully Automated MAGLUMI SARS-CoV-2 IgM/IgG Chemiluminescence Immunoassay at the Point That the Immune Response to the Disease Has Not Been Established Yet

Ayse Istanbullu Tosun & Filiz Yarimcan*

Purpose
There is a need for serological tests to diagnose and manage epidemiologically COVID-19. Several high throughput technologies developed SARS-CoV-2 antibody kits, the performance of which has not been studied yet. We aimed to evaluate MAGLUMI SARS-CoV-2 IgM/IgG Chemiluminescent Immunoassay (Snibe, China). [..] READ MORE

View Full Text | Download PDF

Gut Microbiome and Diabesity in the Era of COVID-19: A Comprehensive Review and Perspective

Amr Saeb, T. M.

Diabesity is a modern epidemic and is commonly considered as a unique entity that indicates the co-occurrence of both T2DM, non-insulin-dependent diabetes or adult-onset diabetes, and obesity. Often, obesity and Type 2 Diabetes Mellitus (T2DM) share an origin, risk factors, and pathophysiology. This condition has been labeled as a deliberate poison, which impact cannot be either controlled or cured. [..] READ MORE

View Full Text | Download PDF

Total Articles Published

8
9
2


Total Citations:

1
8
4




Highlights


Cient Periodique is a ‘Gold’ open access publisher that aspires to offer absolute free, unrestricted access to the valuable research information

We welcome all the eminent authors to submit your valuable paper

Cient Periodique invites the participation of honourable Editors and Authors

CPQ Journals provide Certificates for publication

Cient Periodique also offers memberships for potential Authors

Best Articles will be appreciated with the provision of corresponding Certificate

Hi!

We're here to answer your questions!


Send us a message via Whatsapp, and we'll reply the moment we're available!